Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid

Cardiovascular disease (CVD) represents the leading cause of mortality worldwide. Lifestyle modifications, along with low-density lipoprotein cholesterol (LDL-C) reduction, remain the highest priorities in CVD risk management. Among lipid-lowering agents, statins are most effective in LDL-C reductio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Moutzouri, Elisavet, Kei, Anastazia, Elisaf, Moses S, Milionis, Haralampos J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2010
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2922314/
https://ncbi.nlm.nih.gov/pubmed/20730069
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak